Independent news and intelligence for the evolving peptide industry.
PepNews tracks the developments shaping peptide research, regulation, compounding, telehealth, and the businesses building around them.
Our Story
PepNews was created to make the fast-moving peptide industry easier to follow.
Important developments are happening across research, regulation, compounding, telehealth, pharmaceutical companies, and emerging markets. But the information is often scattered across government documents, scientific publications, company announcements, conference discussions, regulatory filings, and traditional news outlets.
For readers trying to understand what is actually changing, keeping up with all of those sources can become overwhelming.
PepNews brings those developments together in one place — identifying meaningful stories, explaining what happened, showing why it matters, and helping readers find the original information behind the reporting.
Our coverage is designed to go beyond headlines. We look at the broader context surrounding a story, including the regulatory environment, available scientific evidence, industry implications, and what developments may come next.
As the peptide ecosystem continues to grow, our goal is to build a reliable place where readers can follow important developments without having to search through dozens of disconnected sources.
PepNews is not a pharmacy, peptide seller, or medical provider. We are building an independent news and intelligence platform focused on making this evolving industry easier to understand.
Our Principles
The standards that guide how PepNews selects, verifies, and explains stories.
Accuracy
We prioritize credible sources, primary documents, regulatory materials, scientific research, and established reporting. When information is still developing, we make that clear.
Context
A headline rarely tells the whole story. We explain what changed, why it matters, who may be affected, and what readers should watch next.
Independent Coverage
PepNews aims to clearly separate reporting from promotion, sponsorship, and commercial relationships so readers understand what they’re looking at.
What We Cover
PepNews follows the developments shaping the peptide ecosystem — from scientific research and regulatory decisions to compounding, telehealth, and industry activity.
Research & Science
Clinical trials, scientific studies, emerging compounds, and research developments involving peptides and related therapeutics.
Regulation & Policy
FDA actions, compounding policy, enforcement developments, advisory meetings, and regulatory changes affecting the industry.
Industry & Markets
Pharmaceutical companies, telehealth, compounding pharmacies, manufacturing, acquisitions, and broader market developments.
